August 2026
MAIN5 Acquired by Astrix
33Equity is pleased to announce that it has acted as exclusive M&A advisor to MAIN5 on its sale to Astrix, a portfolio company of Quad-C Management, Inc.
About MAIN5
Founded in Frankfurt in 2013, MAIN5 is a management consulting firm supporting leading life sciences organizations with digital transformation, regulatory affairs, quality management, and operational excellence. The company combines specialist industry knowledge with technology expertise to help clients implement and manage business-critical systems in complex, regulated environments.
About Astrix
Astrix is a US-based global provider of pharmaceutical technology services, helping life sciences companies address scientific, technological, and operational challenges. MAIN5’s European consulting presence and specialist capabilities complement Astrix’s existing offering and strengthen its ability to support clients internationally.
Strategic rationale
The transaction will enable MAIN5 to build on its position in the European life sciences market while benefiting from Astrix’s global platform. Backed by Quad-C, the combination provides a foundation to accelerate international expansion, broaden service capabilities, and support clients across increasingly complex digital and regulatory transformation initiatives.
This transaction underscores 33Equity's expertise in advising technology companies on strategic mergers and acquisitions.
